M&A Deal Summary

PharmaLex Acquires The Degge Group

On May 2, 2017, PharmaLex acquired life science company The Degge Group

Acquisition Highlights
  • This is PharmaLex’s 3rd transaction in the Life Science sector.
  • This is PharmaLex’s 2nd transaction in the United States.
  • This is PharmaLex’s 1st transaction in Virginia.

M&A Deal Summary

Date 2017-05-02
Target The Degge Group
Sector Life Science
Buyer(s) PharmaLex
Deal Type Add-on Acquisition

Target

The Degge Group

Arlington, Virginia, United States
The Degge Group Ltd. focuses on pharmacoepidemiology and pharmacovigilance services.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PharmaLex

Frankfurt, Germany

Category Company
Sector Life Science
DESCRIPTION

PharmaLex is a provider of solutions for drug development, regulatory affairs, and pharmacovigilance. The company features a multidisciplinary team from more than 40 nationalities with knowledge that spans the whole spectrum of life sciences, including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology, and veterinary medicine. PharmaLex is based in Frankfurt, Germany.


DEAL STATS #
Overall 5 of 13
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 4 of 10
State (Virginia) 1 of 1
Country (United States) 2 of 4
Year (2017) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-28 Safis Solutions

Indianapolis, Illinois, United States

Safis Solutions LLC is a provider of pharmaceutical, medical device and biotech companies worldwide in meeting health authority requirements.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-01 Complya Consulting Group

Woburn, Massachusetts, United States

Complya Consulting Group LLC is a provider of consulting services on a contract or fee basis.

Buy -